NASDAQ:PLSE Pulse Biosciences (PLSE) Stock Price, News & Analysis $17.07 -0.64 (-3.61%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$16.50▼$18.9550-Day Range$7.81▼$19.5152-Week Range$3.78▼$20.44Volume236,241 shsAverage Volume349,862 shsMarket Capitalization$1.05 billionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Get Pulse Biosciences alerts: Email Address Pulse Biosciences MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestBearish23.01% of Float Sold ShortDividend StrengthN/ASustainability-0.60Upright™ Environmental ScoreNews Sentiment1.00Based on 3 Articles This WeekInsider TradingAcquiring Shares$85,600 Bought Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.34 out of 5 starsMedical Sector762nd out of 936 stocksSurgical & Medical Instruments Industry85th out of 101 stocks N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Pulse Biosciences.Read more about Pulse Biosciences' stock forecast and price target. Previous Next 0.0 Short Interest Percentage of Shares Shorted23.01% of the float of Pulse Biosciences has been sold short.Short Interest Ratio / Days to CoverPulse Biosciences has a short interest ratio ("days to cover") of 10.5, which indicates bearish sentiment.Change versus previous monthShort interest in Pulse Biosciences has recently increased by 12.00%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldPulse Biosciences does not currently pay a dividend.Dividend GrowthPulse Biosciences does not have a long track record of dividend growth. Previous Next 4.2 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScorePulse Biosciences has received a 61.90% net impact score from Upright. Pulse Biosciences seems to create the most significant positive value in categories "Jobs", "Physical diseases", and "Taxes". The positive contribution in the "Physical diseases" impact category is mostly driven by its "Diagnostic and treatment machines", "Medical devices engineering", and "Clinical research services for cancer" products. See details.Environmental SustainabilityThe Environmental Impact score for Pulse Biosciences is -0.60. Previous Next 3.3 News and Social Media Coverage News SentimentPulse Biosciences has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.62 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Pulse Biosciences this week, compared to 2 articles on an average week.Search Interest2 people have searched for PLSE on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Pulse Biosciences to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 5.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Pulse Biosciences insiders have bought more of their company's stock than they have sold. Specifically, they have bought $85,600.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders71.50% of the stock of Pulse Biosciences is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions76.95% of the stock of Pulse Biosciences is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Pulse Biosciences' insider trading history. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Pulse Biosciences is -21.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Pulse Biosciences is -21.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioPulse Biosciences has a P/B Ratio of 21.07. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Pulse Biosciences' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad DarwinTop Stock Unveiled!Ready to discover the standout stock of 2024? We’ve identified a single buy & hold gem that’s poised to redefine your portfolio. Download our exclusive report now and dive into the Insights. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.Get Your Free Report About Pulse Biosciences Stock (NASDAQ:PLSE)Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.Read More PLSE Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PLSE Stock News HeadlinesJuly 22, 2024 | seekingalpha.comHealthcare 2024 Second Half OutlookJuly 20, 2024 | americanbankingnews.comPulse Biosciences (NASDAQ:PLSE) Shares Gap Up to $16.38July 27, 2024 | DTI (Ad)How to build the ultimate dividend portfolioThere’s a free dividend workshop that shows how anyone can build the ultimate dividend workshop in 3 basic steps? PLUS: You’ll get the names and tickers of the Best Dividend Stocks for FREE… This way, by the time you finish the workshop you’ll be fully equipped with the knowledge to start unlocking dividend checks for yourself… Over and over again.July 3, 2024 | businesswire.comPulse Biosciences, Inc. Announces the Closing of its Rights OfferingJune 4, 2024 | businesswire.comPulse Biosciences, Inc. Announces Commencement of Rights OfferingMay 25, 2024 | finance.yahoo.comPresident & CEO of Pulse Biosciences Burke Barrett Buys More StockMay 20, 2024 | businesswire.comPulse Biosciences Announces Updated Timing of Rights Offering for Up to $60,000,000May 16, 2024 | seekingalpha.comPulse Biosciences Stock: Signs Of Life Following Q1 UpdateJuly 27, 2024 | DTI (Ad)How to build the ultimate dividend portfolioThere’s a free dividend workshop that shows how anyone can build the ultimate dividend workshop in 3 basic steps? PLUS: You’ll get the names and tickers of the Best Dividend Stocks for FREE… This way, by the time you finish the workshop you’ll be fully equipped with the knowledge to start unlocking dividend checks for yourself… Over and over again.May 16, 2024 | finance.yahoo.comPulse Biosciences’ CellFX Nanosecond Pulsed Field Ablation (nsPFA™) Technology to be Featured in Several Presentations at The Heart Rhythm Society 2024 Annual MeetingMay 16, 2024 | businesswire.comPulse Biosciences' CellFX Nanosecond Pulsed Field Ablation (nsPFA™) Technology to be Featured in Several Presentations at The Heart Rhythm Society 2024 Annual MeetingMay 14, 2024 | finance.yahoo.comPulse Biosciences Enhances Executive Leadership TeamMay 13, 2024 | finance.yahoo.comPulse Biosciences, Inc. (NASDAQ:PLSE) Q1 2024 Earnings Call TranscriptMay 12, 2024 | uk.investing.comEarnings call: Pulse Biosciences reports progress with CellFX systemMay 11, 2024 | finance.yahoo.comPulse Biosciences Insiders Added US$9.69m Of Stock To Their HoldingsMay 9, 2024 | finance.yahoo.comPulse Biosciences Announces First U.S. Procedure with the CellFX nsPFA Percutaneous Electrode SystemMay 8, 2024 | finance.yahoo.comPulse Biosciences Inc (PLSE) Q1 2024 Earnings Call Transcript Highlights: Strategic ...May 7, 2024 | investorplace.comPLSE Stock Earnings: Pulse Biosciences Reported Results for Q1 2024See More Headlines Receive PLSE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pulse Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/07/2024Today7/26/2024Next Earnings (Estimated)8/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:PLSE CUSIPN/A CIK1625101 Webwww.pulsebiosciences.com Phone(510) 906-4600FaxN/AEmployees140Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.81) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-42,210,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-86.15% Return on Assets-66.87% Debt Debt-to-Equity RatioN/A Current Ratio7.06 Quick Ratio7.06 Sales & Book Value Annual Sales$700,000.00 Price / Sales1,492.89 Cash FlowN/A Price / Cash FlowN/A Book Value$0.81 per share Price / Book21.07Miscellaneous Outstanding Shares61,220,000Free Float15,739,000Market Cap$1.05 billion OptionableOptionable Beta1.75 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesMr. Robert W. Duggan (Age 79)Executive Chairman Key CompetitorsSeaSpineNASDAQ:SPNEUtah Medical ProductsNASDAQ:UTMDAccurayNASDAQ:ARAYCytosorbentsNASDAQ:CTSOUFP TechnologiesNASDAQ:UFPTView All CompetitorsInsiders & InstitutionsBank of New York Mellon CorpBought 9,639 shares on 7/26/2024Ownership: 0.083%Griffin Asset Management Inc.Sold 42,641 shares on 7/23/2024Ownership: 0.467%Westside Investment Management Inc.Bought 31,440 shares on 7/17/2024Ownership: 0.115%Cetera Advisors LLCBought 12,548 shares on 5/24/2024Ownership: 0.023%Burke Thomas BarrettBought 10,000 shares on 5/20/2024Total: $85,600.00 ($8.56/share)View All Insider TransactionsView All Institutional Transactions PLSE Stock Analysis - Frequently Asked Questions How have PLSE shares performed this year? Pulse Biosciences' stock was trading at $12.24 at the beginning of the year. Since then, PLSE stock has increased by 39.5% and is now trading at $17.07. View the best growth stocks for 2024 here. How were Pulse Biosciences' earnings last quarter? Pulse Biosciences, Inc. (NASDAQ:PLSE) announced its quarterly earnings results on Tuesday, May, 7th. The company reported ($0.17) earnings per share for the quarter. What is Darrin R. Uecker's approval rating as Pulse Biosciences' CEO? 2 employees have rated Pulse Biosciences Chief Executive Officer Darrin R. Uecker on Glassdoor.com. Darrin R. Uecker has an approval rating of 100% among the company's employees. This puts Darrin R. Uecker in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. When did Pulse Biosciences IPO? Pulse Biosciences (PLSE) raised $20 million in an initial public offering (IPO) on Wednesday, May 18th 2016. The company issued 5,000,000 shares at a price of $4.00 per share. MDB Capital Group and Feltl and Company served as the underwriters for the IPO. Who are Pulse Biosciences' major shareholders? Top institutional investors of Pulse Biosciences include Griffin Asset Management Inc. (0.47%), Westside Investment Management Inc. (0.12%) and Bank of New York Mellon Corp (0.08%). Insiders that own company stock include Mitchell E Levinson, Kevin Patrick Danahy and Burke Thomas Barrett. View institutional ownership trends. How do I buy shares of Pulse Biosciences? Shares of PLSE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Pulse Biosciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that Pulse Biosciences investors own include Advanced Micro Devices (AMD), AbbVie (ABBV), Bausch Health Companies (BHC), Wayfair (W), Achaogen (AKAO), NVIDIA (NVDA) and Portola Pharmaceuticals (PTLA). This page (NASDAQ:PLSE) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredThe #1 Crypto for 2024 (3 Cent Coin)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pulse Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pulse Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
